Adaptimmune Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $95k | 100k | 0.95 |
| 2024-03-31 | $585k | 370k | 1.58 |
| 2023-12-31 | $403k | 509k | 0.79 |
| 2023-06-30 | $32k | 34k | 0.93 |
| 2023-03-31 | $53k | 49k | 1.09 |
| 2022-12-31 | $206k | 141k | 1.46 |
| 2022-09-30 | $410k | 381k | 1.08 |
| 2022-03-31 | $143k | 70k | 2.05 |
| 2021-12-31 | $315k | 84k | 3.74 |
| 2021-09-30 | $2.5M | 485k | 5.17 |
| 2021-06-30 | $2.2M | 513k | 4.26 |
| 2021-03-31 | $494k | 93k | 5.31 |
| 2020-12-31 | $1.7M | 323k | 5.39 |
| 2020-09-30 | $590k | 74k | 7.98 |
| 2020-03-31 | $52k | 19k | 2.71 |
| 2019-12-31 | $124k | 103k | 1.20 |
| 2019-09-30 | $105k | 70k | 1.51 |
| 2019-06-30 | $232k | 58k | 4.02 |
| 2019-03-31 | $297k | 69k | 4.30 |
| 2018-03-31 | $852k | 76k | 11.22 |
| 2017-06-30 | $242k | 54k | 4.49 |
| 2016-09-30 | $83k | 12k | 7.03 |